Smoking Cessation Pharmacotherapy Coverage
Customize your policy alerts
Sign up for all Arizona Complete Health policy alerts
Know when Arizona Complete Health releases new policies or updates existing guidance.
Monitor payer policy activity
Defines Arizona Complete Health (AHCCCS) coverage, prior authorization, and limits for nicotine replacement therapies and prescription smoking cessation medications for eligible members.
No material clinical or coverage changes in this revision.
Coverage Criteria
General coverage criteria
Covered when ALL of the following are met
Non-Title XIX members are excluded (see exclusions).
Providers should encourage enrollment in ADHS cessation program (1-800-55-66-222).
Coverage is not authorized for the following: Non-Title XIX members; indications other than as an aid for smoking cessation; doses that exceed the FDA maximum allowable; combination treatment with more than one of the listed agents; and specific drug–disease contraindications. These exclusions will result in denial of coverage when encountered during prior authorization or claims review.
Use of more than one tobacco cessation agent concurrently is not authorized and is considered not covered. Combination treatment with multiple listed agents will trigger denial of coverage.
Provider Actions & Authorization
Obtain prior authorization and adhere to supply limits
Prior authorization is required when the member is under 18 years of age; when a brand-name medication is requested but a generic product is available; and for Bupropion 24 hour / Wellbutrin XL. The maximum supply is limited to a 12‑week supply within any six‑month period (the six‑month period begins on the date the first prescription is filled).
- Prior auth required: members under 18 (III.a).
- Prior auth required: brand name when a generic is available (III.b).
- Prior auth required: Bupropion 24 hour / Wellbutrin XL (III.c).
- Supply limit: 12‑week supply per six‑month period starting from first fill (II.c).
Use generic-first (brand needs prior authorization)
Brand-name smoking cessation medications require prior authorization when a generic equivalent is available; providers should prescribe the generic formulation first when clinically appropriate.
- Prior authorization required for brand name when a generic product is available (III.b).
Ensure a PCP prescription is on file
Members must contact their primary care provider (PCP) to obtain a prescription; AHCCCS requires a prescription on file for all tobacco use medications, including products available over‑the‑counter, for coverage.
- Prescription from the member's PCP is required for coverage (II.b).
- This requirement applies to all tobacco cessation products, including OTC items (II.b).
Exclusions that will trigger denial
Do not submit claims or expect coverage for the following — these are explicit exclusions and will result in denial: members who are not Title XIX (AHCCCS) enrollees; use for indications other than smoking cessation; doses greater than the FDA maximum allowable; combination treatment with more than one listed agent; and therapies with specific drug‑disease contraindications.
- Non‑Title XIX members are excluded (IV.a).
- Indications other than smoking cessation are excluded (IV.b).
- Doses greater than the FDA maximum allowable are excluded (IV.c).
- Combination treatment with more than one of the listed agents is not authorized (IV.d).
- Specific drug‑disease condition contraindications will preclude coverage (IV.e).
Background
Tobacco dependence is treated using FDA‑approved smoking cessation products designed to reduce withdrawal symptoms and support quitting. AHCCCS covers these products only when used for smoking cessation; products or regimens outside that indication are excluded. Providers should follow labeled dosing recommendations because doses greater than the FDA maximum allowable are not covered. Combining agents is also disallowed—coverage is restricted to single‑agent therapy per course.
Drug Definitions
Dosing and Initial Therapy Criteria
Dosing and maximums
Dosing regimens and maximums as listed in therapeutic alternatives
Bupropion has several contraindications and precautions.
Dose-dependent nausea common; caution in serious mental illness; long-term safety unknown.
Step Therapy / Formulary Preferences
| Step | Requirement | Notes |
|---|---|---|
| 1 | Brand-name medication requests require prior authorization when an equivalent generic product is available. | Prescriber must obtain prior authorization before dispensing brand if a generic exists; applies to all covered tobacco cessation medications per prior authorization rules. |
Quantity Limits
Site of Care / Billing Source
Pharmacy coverage for dual eligibles / Medicare Part D guidance
For dual-eligible members, medications that are prescription-only and bear the federal legend must be obtained from and covered by the member's Medicare Part D plan; over-the-counter tobacco cessation products are covered by AHCCCS contracted health plans and must be ordered per the Guidelines for Approval.
- Prescription-only, federally labeled medications: obtain and bill to Medicare Part D for dual eligibles.
- Over-the-counter medications: covered by AHCCCS contracted health plans and require a prescription per Section II.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.